Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE
Franky Van Herreweghe*,
Jianqiang Mao,
Frank W. R. Chaplen,
Johan Grooten,
Kris Gevaert*,
Joël Vandekerckhove*, and
Katia Vancompernolle*,,
Departments of *Medical Protein Research and Molecular Biology, Ghent University and Flanders Interuniversity Institute for Biotechnology, K. L. Ledeganckstraat 35, B-9000 Ghent, Belgium; and Department of Bioengineering, Oregon State University, 116 Gilmore Hall, Corvallis, OR 97331
Received for publication August 20, 2001.
Abstract:
Tumor necrosis factor (TNF)-induced cell death in the fibrosarcomacell line L929 is a caspase-independent process that is characterizedby increased production of reactive oxygen species (ROS) inthe mitochondria. To elucidate this ROS-dependent cell deathpathway, a comparative study of the phosphoproteins presentin TNF-treated and control cells was performed. Here we reportthat TNF induces an increased phosphorylation of glyoxalaseI that is mediated by protein kinase A and required for celldeath. We also show that TNF induces a substantial increasein intracellular levels of methylglyoxal (MG) that leads tothe formation of a specific MG-derived advanced glycation endproduct and that this formation occurs as a consequence of increasedROS production. These data indicate that MG modification ofproteins is a targeted process and that MG may thus functionas a signal molecule during the regulation of cell death. Furthermore,we provide evidence that the TNF-induced phosphorylation ofglyoxalase I is not involved in detoxification of MG by meansof the glyoxalase system, but that phosphorylated glyoxalaseI is on the pathway leading to the formation of a specific MG-derivedadvanced glycation end product.
To whom reprint requests should be addressed at the presentaddress: Department of Medical Protein Research, Albert Baertsoenkaai3, 9000 Ghent, Belgium. E-mail: katia.vancompernolle{at}rug.ac.be.
Edited by Anthony Cerami, The Kenneth S. Warren Institute, Tarrytown,NY, and approved October 31, 2001
This paper was submitted directly (Track II) to the PNAS office.
¶ Kim, Y. H. & Kim, S. S. (2001) Cancer Detect. Prev.24,Suppl. 1 (abstr.).
The editors suggest the following Related Resources on Science sites:
Jonathan P. Godbout, James Pesavento, Matthew E. Hartman, Scott R. Manson, and Gregory G. Freund (18 January 2002) J. Biol. Chem.277 (4), 2554.
[DOI: 10.1074/jbc.M100385200] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Mitochondrial Control of Cellular Life, Stress, and Death.
L. Galluzzi, O. Kepp, C. Trojel-Hansen, and G. Kroemer (2012)
Circ. Res.
111, 1198-1207
|Abstract »|Full Text »|PDF »
The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis.
P. Vandenabeele, W. Declercq, F. Van Herreweghe, and T. Vanden Berghe (2010)
Science Signaling
3, re4
|Abstract »|Full Text »|PDF »
Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats.
T. Kumagai, M. Nangaku, I. Kojima, R. Nagai, J. R. Ingelfinger, T. Miyata, T. Fujita, and R. Inagi (2009)
Am J Physiol Renal Physiol
296, F912-F921
|Abstract »|Full Text »|PDF »
High Glucose Increases Angiopoietin-2 Transcription in Microvascular Endothelial Cells through Methylglyoxal Modification of mSin3A.
D. Yao, T. Taguchi, T. Matsumura, R. Pestell, D. Edelstein, I. Giardino, G. Suske, N. Rabbani, P. J. Thornalley, V. P. Sarthy, et al. (2007)
J. Biol. Chem.
282, 31038-31045
|Abstract »|Full Text »|PDF »
Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice.
M. T. Barati, M. L. Merchant, A. B. Kain, A. W. Jevans, K. R. McLeish, and J. B. Klein (2007)
Am J Physiol Renal Physiol
293, F1157-F1165
|Abstract »|Full Text »|PDF »
Phosphoproteomic identification of targets of the Arabidopsis sucrose nonfermenting-like kinase SnRK2.8 reveals a connection to metabolic processes.
R. Shin, S. Alvarez, A. Y. Burch, J. M. Jez, and D. P. Schachtman (2007)
PNAS
104, 6460-6465
|Abstract »|Full Text »|PDF »
CpG Immunomer DNA Enhances Antisense Protein Kinase A RI{alpha} Inhibition of Multidrug-Resistant Colon Carcinoma Growth in Nude Mice: Molecular Basis for Combinatorial Therapy.
M. V. Nesterova, N. R. Johnson, T. Stewart, S. Abrams, and Y. S. Cho-Chung (2005)
Clin. Cancer Res.
11, 5950-5955
|Abstract »|Full Text »|PDF »
Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury.
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg (2005)
J. Pharmacol. Exp. Ther.
313, 88-94
|Abstract »|Full Text »|PDF »
The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway.
H.-Y. Lee, Y. Xu, Y. Huang, A. H. Ahn, G. W.J. Auburger, M. Pandolfo, H. Kwiecinski, D. A. Grimes, A. E. Lang, J. E. Nielsen, et al. (2004)
Hum. Mol. Genet.
13, 3161-3170
|Abstract »|Full Text »|PDF »
Role for glyoxalase I in Alzheimer's disease.
F. Chen, M. A. Wollmer, F. Hoerndli, G. Munch, B. Kuhla, E. I. Rogaev, M. Tsolaki, A. Papassotiropoulos, and J. Gotz (2004)
PNAS
101, 7687-7692
|Abstract »|Full Text »|PDF »
Rapid Suppression of Mitochondrial Permeability Transition by Methylglyoxal: ROLE OF REVERSIBLE ARGININE MODIFICATION.
O. Speer, S. Morkunaite-Haimi, J. Liobikas, M. Franck, L. Hensbo, M. D. Linder, P. K. J. Kinnunen, T. Wallimann, and O. Eriksson (2003)
J. Biol. Chem.
278, 34757-34763
|Abstract »|Full Text »|PDF »
M. Portero-Otin, R. Pamplona, M. J. Bellmunt, M. C. Ruiz, J. Prat, R. Salvayre, and A. Negre-Salvayre (2002)
Diabetes
51, 1535-1542
|Abstract »|Full Text »|PDF »